HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,544,982 | -1.5% | 17,247 | -6.3% | 0.06% | +3.2% |
| Q2 2023 | $1,568,000 | +3.0% | 18,416 | +0.1% | 0.06% | +1.6% |
| Q1 2023 | $1,523,000 | +2.7% | 18,402 | -2.4% | 0.06% | +7.0% |
| Q4 2022 | $1,483,000 | +122.7% | 18,859 | +225.2% | 0.06% | +171.4% |
| Q4 2019 | $666,000 | -9.0% | 5,800 | 0.0% | 0.02% | -12.5% |
| Q3 2019 | $732,000 | -15.5% | 5,800 | -19.4% | 0.02% | -14.3% |
| Q2 2019 | $866,000 | +37.5% | 7,200 | 0.0% | 0.03% | +40.0% |
| Q1 2019 | $630,000 | -7.4% | 7,200 | +5.9% | 0.02% | -13.0% |
| Q4 2018 | $680,000 | -12.7% | 6,800 | 0.0% | 0.02% | +4.5% |
| Q3 2018 | $779,000 | +27.7% | 6,800 | 0.0% | 0.02% | -21.4% |
| Q2 2018 | $610,000 | -12.2% | 6,800 | -28.4% | 0.03% | -9.7% |
| Q1 2018 | $695,000 | -19.7% | 9,500 | -36.2% | 0.03% | -13.9% |
| Q4 2017 | $865,000 | – | 14,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |